Barclays raised the firm’s price target on Procter & Gamble to $174 from $170 and keeps an Overweight rating on the shares. The analyst believes the macro backdrop and/or relative valuations “present a difficult investment landscape” within U.S. consumer staples heading into the Q2 reports. Food valuations appear attractive, though the fundamentals largely do not, the analyst tells investors in a research note. The firm says it “feels difficult to find pockets of meaningful upside potential at either end of the spectrum right now.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $176 from $171 at Deutsche Bank
- Procter & Gamble price target raised to $190 from $177 at Citi
- Procter & Gamble Unveils Stock Market Investment Strategies
- Savvy Shopping Habits Impact Staples Companies’ Profits
- Playtex maker ticks lower after UC Berkeley study on tampon toxins
Questions or Comments about the article? Write to editor@tipranks.com